• [email protected]
  • +971 507 888 742
Submit Manuscript
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 15 (4), 2019
  3. 486-493
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2019 | Volume: 15 | Issue: 4 | Page No.: 486-493
DOI: 10.3923/ijp.2019.486.493

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 50

Authors


Ertuğrul Ertuğrul

Country: Turkey

Aydın Kahraman

Country: Turkey

Emre  Mutlu

Emre Mutlu

LiveDNA: 90.25281

Emre Elçi

Country: Turkey

Keywords


  • ADMA
  • GSH
  • Ischemia
  • MDA
  • reperfusion injury
  • ticagrelor
Research Article

Effects of Ticagrelor on Skeletal Muscle Viability, Asymmetric Dimethylarginine, Malondialdehyde and Glutathione in Ischemia-reperfusion Model

Ertuğrul Ertuğrul, Aydın Kahraman, Emre Mutlu Emre  Mutlu's LiveDNA and Emre Elçi
Background and Objective: Although many agents have successful clinical results in experimental studies in order to prevent ischemia-reperfusion (I-R) injury, only a few of them have come into use clinically. In this study, the effects of ticagrelor-a new antiplatelet agent on skeletal muscle viability and blood asymmetric dimethylarginine, malondialdehyde and glutathione levels after experimental ischemia-reperfusion injury of lower limb have been analyzed. Materials and Methods: In this study, 21 male rats have been used. To induce lower limbischemia surgically at the ischemia-reperfusion group (n = 7) and ticagrelor group (n = 7) it clamped Infrarenal Abdominal Aorta (IAA) for 2 h after that were moved the clamp for reperfusion for 2 h. At the end of reperfusion, muscle tissue and blood samples of the rats were taken by sacrificing and excising their soleus muscles. Histopathological search was made in tissue samples and ADMA, MDA, GSH levels were studied in blood and muscle tissue. Results: The ADMA and MDA levels in blood and muscle tissue were more increased on I-R group than control group. This increase was less in ticagrelor administered group. Blood GSH levels were significantly more increased in the I-R group than control group. Compared to I-R group it was significantly decreased in ticagrelor group. Increase of muscle tissue GSH level was more significant in I-R group than in control group. In ticagrelor group muscle tissue GSH level was decreased significantly compared to I-R group. Conclusion: It was observed that ticagrelor reduces oxidant level and injury of skeletal muscle at lower limb ischemia-reper fusion injury. It is observed that ticagrelor is protective against ischemia-reperfusion injury.
PDF Fulltext XML References Citation

How to cite this article

Ertuğrul Ertuğrul, Aydın Kahraman, Emre Mutlu and Emre Elçi, 2019. Effects of Ticagrelor on Skeletal Muscle Viability, Asymmetric Dimethylarginine, Malondialdehyde and Glutathione in Ischemia-reperfusion Model. International Journal of Pharmacology, 15: 486-493.

DOI: 10.3923/ijp.2019.486.493

URL: https://scialert.net/abstract/?doi=ijp.2019.486.493

Leave a Reply


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved